Therma Bright Inc. (TBRIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0537
+0.0063 (13.27%)
Jul 11, 2025, 4:00 PM EDT
Therma Bright Revenue
Therma Bright had revenue of 1.81K CAD in the quarter ending April 30, 2025. This brings the company's revenue in the last twelve months to 30.62K, down -378.10% year-over-year. In the fiscal year ending July 31, 2024, Therma Bright had annual revenue of 6.02K with 192.56% growth.
Revenue (ttm)
30.62K CAD
Revenue Growth
-378.10%
P/S Ratio
131.08
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.91M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 6.02K | 3.96K | 192.56% |
Jul 31, 2023 | 2.06K | -137.37K | -98.53% |
Jul 31, 2022 | 139.43K | 135.54K | 3,490.70% |
Jul 31, 2021 | 3.88K | 100.00 | 2.64% |
Jul 31, 2020 | 3.78K | -3.12K | -45.21% |
Jul 31, 2019 | Pro | Pro | Pro |
Jul 31, 2018 | Pro | Pro | Pro |
Jul 31, 2017 | Pro | Pro | Pro |
Jul 31, 2016 | Pro | Pro | Pro |
Jul 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
Therma Bright News
- 11 days ago - Therma Bright Announces Share Consolidation - Newsfile Corp
- 4 weeks ago - Therma Bright announces 8-for-1 share consolidation - Seeking Alpha
- 4 weeks ago - Therma Bright Inc. Announces Share Consolidation - Newsfile Corp
- 5 weeks ago - Therma Bright Proposes to Amend Certain Warrants and Negotiates Debt Settlements - Newsfile Corp
- 2 months ago - Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin - Newsfile Corp
- 2 months ago - Therma Bright Secures New Customer Initial Purchase Order, Signaling Market Confidence - Newsfile Corp
- 3 months ago - Therma Bright Reviews Manufacturing Strategy in Light of US Tariff Changes - Newsfile Corp
- 4 months ago - Therma Bright gets contract for consumer product devices - Seeking Alpha